90 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Will Trinity Biotech Stock Gain From Its Latest Patent Process? https://www.zacks.com/stock/news/2334051/will-trinity-biotech-stock-gain-from-its-latest-patent-process?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2334051 Sep 10, 2024 - TRIB announces updates on its European patented process. The company aims to use this process to improve the functionality of its glucose biosensor in its next-gen CGM technology.
5 Top Red-Hot Stocks to Buy Now https://www.zacks.com/stock/news/2333652/5-top-red-hot-stocks-to-buy-now?cid=CS-ZC-FT-market_edge-2333652 Sep 09, 2024 - he hottest stocks might not be those you think. Look past AI and technology stocks.
Here's Why Universal Health Shares are Attracting Investors Now https://www.zacks.com/stock/news/2333633/here-s-why-universal-health-shares-are-attracting-investors-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2333633 Sep 09, 2024 - UHS remains well-poised for growth on improved patient days at its behavioral healthcare facilities, acquisitions and solid cash flows.
PBH Stock Might Get a Boost From Focused Brand-Building Efforts https://www.zacks.com/stock/news/2333619/pbh-stock-might-get-a-boost-from-focused-brand-building-efforts?cid=CS-ZC-FT-analyst_blog|zer_report_update-2333619 Sep 09, 2024 - Prestige Consumer puts emphasis on brand building and product innovation in niche consumer healthcare categories to improve the lives of its consumers.
New Partnerships to Aid Myriad Genetics Stock Amid Macro Issues https://www.zacks.com/stock/news/2331577/new-partnerships-to-aid-myriad-genetics-stock-amid-macro-issues?cid=CS-ZC-FT-analyst_blog|zer_report_update-2331577 Sep 04, 2024 - MYGN focuses on effective capital deployment in key areas, including new tech-enabled tools and capabilities, innovation and commercial capabilities.
Reasons to Hold Tandem Diabetes Stock in Your Portfolio Now https://www.zacks.com/stock/news/2330816/reasons-to-hold-tandem-diabetes-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2330816 Sep 03, 2024 - Innovations and a robust diabetes market outlook raise investors' optimism for TNDM.
Favorable Clinical Results for HYLA Sensor Might Boost Inspira Stock https://www.zacks.com/stock/news/2330140/favorable-clinical-results-for-hyla-sensor-might-boost-inspira-stock?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2330140 Sep 02, 2024 - IINN plans to report clinical results for its new HYLA blood sensor in open-heart surgery patients in the fourth quarter of 2024.
Market Share Gains Aid Zimmer Biomet Stock Amid Cost Pressure https://www.zacks.com/stock/news/2329694/market-share-gains-aid-zimmer-biomet-stock-amid-cost-pressure?cid=CS-ZC-FT-analyst_blog|zer_report_update-2329694 Aug 30, 2024 - In terms of Persona cementless Knee, ZBH is currently witnessing strong uptake of the cementless platform Persona OsseoTi.
New Launches Support Tandem Diabetes Stock Despite Macro Concerns https://www.zacks.com/stock/news/2329688/new-launches-support-tandem-diabetes-stock-despite-macro-concerns?cid=CS-ZC-FT-analyst_blog|zer_report_update-2329688 Aug 30, 2024 - The latest addition to TNDM's pump platform portfolio, Tandem Mobi, is leading the way in creating a whole new category of devices for insulin therapy.
2 Top Healthcare Growth Stocks to Buy Right Now https://www.fool.com/investing/2024/08/30/2-top-healthcare-growth-stocks-to-buy-right-now/?source=iedfolrf0000001 Aug 30, 2024 - These businesses are profitable and growing steadily.

Pages: 1234567...9

<Page 2>